Literature DB >> 26013997

Regulation of NANOG in cancer cells.

Shuai Gong1,2, Qiuhui Li1, Collene R Jeter1, Qingxia Fan2, Dean G Tang1,3, Bigang Liu1.   

Abstract

As one of the key pluripotency transcription factors, NANOG plays a critical role in maintaining the self-renewal and pluripotency in normal embryonic stem cells. Recent data indicate that NANOG is expressed in a variety of cancers and its expression correlates with poor survival in cancer patients. Of interest, many studies suggest that NANOG enhances the defined characteristics of cancer stem cells and may thus function as an oncogene to promote carcinogenesis. Therefore, NANOG expression determines the cell fate not only in pluripotent cells but also in cancer cells. Although the regulation of NANOG in normal embryonic stem cells is reasonably well understood, the regulation of NANOG in cancer cells has only emerged recently. The current review provides a most updated summary on how NANOG expression is regulated during tumor development and progression.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  NANOG; NANOGP8; cancer stem cells; tumor development

Mesh:

Substances:

Year:  2015        PMID: 26013997      PMCID: PMC4536084          DOI: 10.1002/mc.22340

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  80 in total

1.  Identification of a tumor-initiating stem cell population in human renal carcinomas.

Authors:  Benedetta Bussolati; Stefania Bruno; Cristina Grange; Ugo Ferrando; Giovanni Camussi
Journal:  FASEB J       Date:  2008-07-09       Impact factor: 5.191

Review 2.  Regulation of pluripotency and reprogramming by transcription factors.

Authors:  Duanqing Pei
Journal:  J Biol Chem       Date:  2008-09-26       Impact factor: 5.157

3.  Hepatitis C virus core protein regulates NANOG expression via the stat3 pathway.

Authors:  Jia-Jia Zhou; Ru-Fu Chen; Xiao-Geng Deng; Yu Zhou; Xiao Ye; Min Yu; Jing Tang; Xiao-Yu He; Di Cheng; Bing Zeng; Quan-bo Zhou; Zhi-hua Li
Journal:  FEBS Lett       Date:  2014-01-21       Impact factor: 4.124

4.  Over-expression of Nanog predicts tumor progression and poor prognosis in colorectal cancer.

Authors:  Hui-Min Meng; Ping Zheng; Xiao-Yan Wang; Chao Liu; Hong-Mei Sui; Shao-Jie Wu; Jun Zhou; Yan-Qing Ding; Jianming Li
Journal:  Cancer Biol Ther       Date:  2009-12-22       Impact factor: 4.742

5.  Activated 5'flanking region of NANOGP8 in a self-renewal environment is associated with increased sphere formation and tumor growth of prostate cancer cells.

Authors:  Kai Zhang; Marcie Fowler; Jonathan Glass; Hong Yin
Journal:  Prostate       Date:  2013-12-07       Impact factor: 4.104

6.  Prognostic significance of NANOG and KLF4 for breast cancer.

Authors:  Takuya Nagata; Yutaka Shimada; Shinichi Sekine; Ryota Hori; Koshi Matsui; Tomoyuki Okumura; Shigeaki Sawada; Junya Fukuoka; Kazuhiro Tsukada
Journal:  Breast Cancer       Date:  2012-04-17       Impact factor: 4.239

7.  Hypoxia promotes stem-like properties of laryngeal cancer cell lines by increasing the CD133+ stem cell fraction.

Authors:  Chun-Ping Wu; Huai-Dong Du; Hong-Li Gong; Da-Wei Li; Lei Tao; Jie Tian; Liang Zhou
Journal:  Int J Oncol       Date:  2014-02-20       Impact factor: 5.650

8.  Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance.

Authors:  Ayesha B Alvero; Rui Chen; Han-Hsuan Fu; Michele Montagna; Peter E Schwartz; Thomas Rutherford; Dan-Arin Silasi; Karina D Steffensen; Marianne Waldstrom; Irene Visintin; Gil Mor
Journal:  Cell Cycle       Date:  2009-01-01       Impact factor: 4.534

9.  NANOG is multiply phosphorylated and directly modified by ERK2 and CDK1 in vitro.

Authors:  Justin Brumbaugh; Jason D Russell; Pengzhi Yu; Michael S Westphall; Joshua J Coon; James A Thomson
Journal:  Stem Cell Reports       Date:  2014-01-14       Impact factor: 7.765

10.  Phosphorylation of Nanog is essential to regulate Bmi1 and promote tumorigenesis.

Authors:  X Xie; L Piao; G S Cavey; M Old; T N Teknos; A K Mapp; Q Pan
Journal:  Oncogene       Date:  2013-05-27       Impact factor: 9.867

View more
  36 in total

1.  Cartilage to bone transformation during fracture healing is coordinated by the invading vasculature and induction of the core pluripotency genes.

Authors:  Diane P Hu; Federico Ferro; Frank Yang; Aaron J Taylor; Wenhan Chang; Theodore Miclau; Ralph S Marcucio; Chelsea S Bahney
Journal:  Development       Date:  2017-01-15       Impact factor: 6.868

Review 2.  NANOG expression in human development and cancerogenesis.

Authors:  Gašper Grubelnik; Emanuela Boštjančič; Ana Pavlič; Marina Kos; Nina Zidar
Journal:  Exp Biol Med (Maywood)       Date:  2020-02-10

3.  Expression patterns and clinical significance of the potential cancer stem cell markers OCT4 and NANOG in colorectal cancer patients.

Authors:  Raheleh Roudi; Mahboubeh Barodabi; Zahra Madjd; Giandomenico Roviello; Silvia Paola Corona; Mahshid Panahei
Journal:  Mol Cell Oncol       Date:  2020-07-14

4.  Prolyl hydroxylase 3 stabilizes the p53 tumor suppressor by inhibiting the p53-MDM2 interaction in a hydroxylase-independent manner.

Authors:  Yiming Xu; Qiang Gao; Yaqian Xue; Xiuxiu Li; Liang Xu; Chenwei Li; Yanqing Qin; Jing Fang
Journal:  J Biol Chem       Date:  2019-05-15       Impact factor: 5.157

Review 5.  Histone modifiers at the crossroads of oncolytic and oncogenic viruses.

Authors:  Sara A Murphy; Norman John Mapes; Devika Dua; Balveen Kaur
Journal:  Mol Ther       Date:  2022-02-08       Impact factor: 12.910

6.  Metformin and AICAR regulate NANOG expression via the JNK pathway in HepG2 cells independently of AMPK.

Authors:  Chen Shen; Sun-O Ka; Su Jin Kim; Ji Hye Kim; Byung-Hyun Park; Ji Hyun Park
Journal:  Tumour Biol       Date:  2016-03-03

7.  Utility of BMI-1 and NANOG expression levels in survival prediction of pediatric acute lymphoblastic leukemia.

Authors:  Sara Abdel-Khalek; Layla M Saleh; Sherin Abdel-Aziz; Ayman Hyder; Hasan Abdel-Ghaffar
Journal:  Hematol Transfus Cell Ther       Date:  2020-03-13

8.  NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR/FOXA1 signaling axis.

Authors:  Collene R Jeter; Bigang Liu; Yue Lu; Hsueh-Ping Chao; Dingxiao Zhang; Xin Liu; Xin Chen; Qiuhui Li; Kiera Rycaj; Tammy Calhoun-Davis; Li Yan; Qiang Hu; Jianmin Wang; Jianjun Shen; Song Liu; Dean G Tang
Journal:  Cell Discov       Date:  2016-11-15       Impact factor: 10.849

9.  Establishment and Characterization of a Human Small Cell Osteosarcoma Cancer Stem Cell Line: A New Possible In Vitro Model for Discovering Small Cell Osteosarcoma Biology.

Authors:  Gaia Palmini; Roberto Zonefrati; Cecilia Romagnoli; Alessandra Aldinucci; Carmelo Mavilia; Gigliola Leoncini; Alessandro Franchi; Rodolfo Capanna; Maria Luisa Brandi
Journal:  Stem Cells Int       Date:  2016-08-29       Impact factor: 5.443

10.  Transgenic overexpression of NanogP8 in the mouse prostate is insufficient to initiate tumorigenesis but weakly promotes tumor development in the Hi-Myc mouse model.

Authors:  Bigang Liu; Shuai Gong; Qiuhui Li; Xin Chen; John Moore; Mahipal V Suraneni; Mark D Badeaux; Collene R Jeter; Jianjun Shen; Rashid Mehmood; Qingxia Fan; Dean G Tang
Journal:  Oncotarget       Date:  2017-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.